Cybin (TSE:CYBN) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Cybin Inc., a leader in neuropsychiatry treatments, announced that their Chief Medical Officer will participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. The company specializes in innovative therapies for mental health conditions, including a psilocin program for depression and a DMT program for anxiety that are advancing through clinical trials.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
